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followed at Kuopio University Hospital (Kuopio, Finland) and 
at oral Pathology Departments of catholic University (rome, 
italy), to evaluate the economic burden of olP. Direct costs 
concerning diagnostic procedures (i.e., biopsies, swabs, blood 
exams), therapeutic management (either local and/or system-
ic) and follow-up visits were obtained from clinical records.
reSUltS: one hundred and eight patients with confirmed 
diagnosis of olP (81 females and 27 male), 50 Finnish and 
58 italians, with a mean age of 60.8, were enrolled in this 
study. Buccal mucosa (81%) and gingiva (48%) were the most 
involved sites, followed by the tongue (37%). considering 
clinical presentation, 59 patients (54.6%) had mixed form, 
32 the red (29.6%) and 17 white form (15.7%). the mean 
follow-up was 24.58 months with a mean of 8.6 visits per 
patient (4.2 times per year). the study population was divided 
into two subgroups according to need of therapy: 73 subjects 
received therapy (group 1) and 35 did not (group 2). group 
1 had a mean follow-up time of 30 months, receiving a mean 
of 10.4 visits (range 2-36; 4.2 per year), 1.4 biopsies (range 
1-3; 0.57 per year) and 1.9 swabs (range 0-17; 0.7 per year) 
with a mean of 395 applications of immunosuppressive topical 
therapy (range 24-2610; 132 administrations per year) and 273 
administrations of topical anti-mycotic (range 21-2264; 96 
administrations per year); group 2 had a mean follow-up time 
of 14 months, receiving a mean of 5.1 visits (range 1-17; 4.4 
per year), 1.2 biopsies (range 1-3; 1.0 per year) and 0.5 swabs 
(0.4 per year). Within each group, it was possible to compare 
costs between Finnish and italian patients: in group 1 (treated 
patients) the mean cost was 1249 euros per Finnish patient, 
whereas 398 euros per italian patient; in group 2 (untreated 
patients) the mean cost was 805 euros per Finnish patient, 
whereas 352 euros per italian patient.
coNclUSioNS: this multicentric study provides a pre-
liminary estimate of olP patients management cost: the most 
interesting aspect was the different economic burden between 
Finnish and italian Health care Systems, being the Finnish 
one more expensive. Moreover, in both health care systems, 
to undergo therapy for olP highly increased the economic 
impact. Some difficulties were encountered during the study, 
in fact many different pharmacological regiments were adopt-
ed, due to variable clinical response to therapy. Since olP is 
considered a potentially malignant disorder, future studies 
should address the impact of neoplastic transformation on the 
economic burden of this disease.
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BacKgroUND: traditional treatment of malignancies with 
chemotherapeutic agents often cause the damage of normal 
healthy cells. oral toxicities are a common cause of dose 
delays and interruption of cancer therapy. in the last decades, 
new targeted agents have been developed aiming to decrease 
the rate of side effects on healthy cells. Multitargeted tyrosine 
kinase inhibitors (tKi) represent a class of target specific anti-
neoplastic agents. even this kind of targeted therapy based 
cancers was performed with intra-operative exam of resection 
margins; definitive histological exam to assess HPP. Follow-
up performed with clinical exam and ultrasonographical 
evaluation of neck’s nodes, in order to perform lymphad-
enectomy only on pathological ones. Medical records were 
collected for each patient, focusing on risk factor, clinical 
presentation, site and W.H.o.’s sub-site classifications, and 
HPP used (grading, tt, tD, histological structures invaded 
by cancer, like muscles, vessels, nerves, salival ducts). HPP’s 
correlation with occurrence of nodal metastasis was assessed 
with Ȥ-test (1 J.l. and α005) then compared to select the 
more reliable ones.
reSUltS: the database gathered 85 cases of oral tongue 
cancer occurred from 2005 to 2015. the early tongue cancer 
affects more males (58,82%), during the seventh decade of 
life (31,74%), occurring on tongue’s lateral margins more 
frequently (77,64%) than other tongue’s sub-sites, in form 
of ulcer (54,11%) or of exophytic mass (31,76%). the early 
tongue cancers are often of stage one (56,47%) and rarely 
of stage zero (2,35%), according to ctNM stadiation. the 
most frequent histological form is invasive (98,83%) well-
differentiated (52,94%) carcinoma, with a large nest invasion 
pattern (75,29%) extended to the extrinsic muscles of tongue 
(72,94%) and rarely extended to vessels (7,06%), nerves 
(17,65%) or salival ducts (15,29%). Few lyphadenectomies 
were performed (10,58%), with only two cases of occult 
metastasis in nodes that needed a ptNM re-stadiation to third 
stage (2%). the 98,73% of patients involved in this study is 
still alive, documented by a follow up period lasting from 2 to 
12 years. only one died because of multiple carcinomas and 
6 because of other reasons. our statistical analysis allowed to 
correlate all HPP to occurrence of nodal metastasis (except 
tt) with statistical significativity. the HPP more predict-
able are: grading, tD, invasion of intrinsic muscles of tongue, 
invasion pattern, vascular invasion.
coNclUSioNS:this study about the early tongue cancer 
proves the efficacy of the management used in odonto-
Stomatology’s Unit of Universty of Bari revealing a 98,73% 
of patients without carcinomas in a period from 2 to 12 years. 
the main Histological Prognostic Parameters useful to evalu-
ate the risk of nodal metastasis are: grading, tD, invasion 
pattern (proper of oScc), vascular invasion and invasion 
of the intrinsic muscles of tongue (exclusive of early tongue 
cancers). tt can’t be considered as a HPP useful for early 
tongue cancer.
Cost of illness of oral lichen planus: prelimi-
nary report of a multicentric study
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BacKgroUND: to estimate the economic costs of oral 
lichen planus (olP) through an out-patient multicentric study 
conducted in Finland and in italy.
MetHoDS: a multicentric retrospective study was conduct-
ed, retrieving clinical records of patients affected by olP and 
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statistical and clinical aspects of celiac Disease. Hypoplasia 
from grade 0 to grade iV were observed, according to aine 
classification based on the symmetry and the bilateralism of 
the lesions and on the chronological coherence.
reSUltS: after objective examinations, 10.5% of patients 
did not show any defect of the enamel, while in  89.5%  these 
alterations appear with a variable frequency,  with a total of 
221 affected   teeth.  grade i lesions occur with a frequency 
of 68%, grade ii lesions in 15%, grade iii lesions in 12%, 
grade iV lesions in 5%.  the most affected teeth were the 
incisors (frequency of 41%) followed by molars (frequency 
of 28%). the third incisal is the most involved dental portion 
(48% frequency). the manifestation of raS occurred in 61% 
of cases and, after  a  gluten-free diet, ulcers disappeared or 
decreased  in 77% of cases.
coNclUSioNS: the results obtained with this study repre-
sent a significant statistical value that supports the possibility 
to use such clinical manifestations as markers of cD in those 
forms that manifest themselves in a non-specific way and to 
consider them equal to all other atypical clinical manifesta-
tions related to it. Starting from an objective examination of 
the oral cavity, the doctor  may consider necessary to inves-
tigate about the familiarity with cD and any other signs and 
symptoms  related to it and, therefore, decide whether and 
what exams require to make an early diagnosis.
Oral amelanotic melanoma of the hard palate: 
a case report
a. tempesta, l. limongelli, P. Mezzapesa, S. Di Nanna, g. 
Barile, a. De caro, g. Favia
Complex Operating Unit of Oral Pathology and Surgery, De-
partment of Interdisciplinary Medicine, University of Bari, Bari, 
Italy
BacKgroUND: oral melanoma is an uncommon malignant 
neoplasm which arises from  melanocytes; the amelanotic 
one is extremely rare in oral cavity. oral melanomas have 
unknown etiology because the affected sites are not exposed 
to solar radiations, however some studies have underlined a 
possible role of ill-fitting dentures, tobacco, amalgam tatoo, 
nevus and racial pigmentation as risk factors. this malignant 
neoplasm is really aggressive therefore an early diagnosis is 
mandatory to improve patient prognosis. Since an early diag-
nosis is difficult, amelanotic melanoma has a poorer prognosis 
than the pigmented one. immunohistochemical staining is 
crucial for the histological diagnosis. the aim of this work is 
to describe a case of oral amelanotic melanoma occurred in a 
50-years-old male patient.
caSe rePort: in november 2017 a 50-years-old male 
patient, 10 cigarettes/day smoker since 20 years old, referred 
to complex operating Unit of oral Pathology and Surgery, 
University of Bari, with a wide bleeding and painless lesion 
on the anterior and left hard palate. clinical oral examina-
tion revealed a swelled, ulcerated, reddish and multi-lobular 
lesion with a firm-elastic consistency. ortopantomography 
(oPt) and computed tomography (ct) with 3D reconstruc-
tion showed the presence of a wide and expansive osteolyt-
ic lesion involving the anterior part of the hard palate and 
extending on the left hard palate and the left nasal floor. Fine 
Needle aspiration citology (FNac), Fine Needle aspiration 
Biopsy (FNaB) and incisional biopsy were performed to 
obtain a certain pre-surgical histopathological diagnosis. 
Hystological features revealed a low differentiated malig-
nant neoplasia with high replication index ( Ki67 > 90% ) 
on Vr-tKi shown some class specific adverse events that 
include fatigue/asthenia, anorexia/loss of appetite, hand-foot 
reations, dysgeusia, diarrhea/abdominal pain, hypothyroidism, 
hypertension, myelosuppression and stomatitis. literature 
reports that one quarter of patients treated with multitargeted 
angiogenesis kinase inhibitors develop an oral adverse event 
within 2 months of therapy.
MetHoDS: the following review was performed  to answer 
to the question “What is the rate of incidence of oral stomatitis 
in patients treated with VegF tKis?”. a systematic search 
was performed on the PubMed online database using a com-
bination of MeSH terms and free text words: “sunitinib”(free 
text) or “sorafenib” (free text) or “axitinib” (free text) or 
“cabozantinib” (free text) or “pazopanib” (free text) or 
“regorafenib” (free text) or “nintenadib” (free text) or 
“vatalanib” (free text) combined through the use of Boolean 
operator aND with the key words “stomatitis” (MeSH) or 
“mucositis” (MeSH). (i) performed on human subjects, (ii) 
reporting about the use of an mtor inhibitor, (iii) written in 
the english language, and (iv) reporting about the incidence 
of stomatitis or oral mucositis. case reports and studies on 
animal model were excluded from this study. No restrictions 
were applied to the year of publication.
reSUltS: the incidence of stomatitis of any grade accord-
ing to the agent was 35,2% for sunitinib, 20.52% for sorafenib, 
20.63% for axitinib and 34.21% for cabozantinib. all the 
agents showed high rates of low grade stomatitis (g1-g2) 
while the onset of sever stomatitis (g3-g4) was low.
coNclUSioNS: analysis of the reports with patients treated 
with sunitinib, sorafenib, axitinib and cabozantinib showed a 
clear prevalence of stomatitis grade 1 or 2. these data differ 
from that of patients treated with conventional chemotherapy 
in which mucositis is predominantly of grade 3 or 4.
Celiac disease and clinical manifestations in the 
oral cavity in the pediatric patient 
c. Dargenio 1, S. cefola 2, a. Sinesi 2,  g. giannatempo 1, l. lo 
russo 1,  g. la torretta 1, e. lo Muzio 3
1Dipartimento di Medicina Clinica e Sperimentale , Università 
di Foggia, Foggia, Italy; 2Associazione Italiana Celiachia, 
Puglia, Italy; 3Dipartimento di Scienze Odontostomatologiche 
e Maxillo-Facciali, Università di Roma La Sapienza, Rome, 
Italy
BacKgroUND: celiac Disease (cD) is extremely variable: 
it may arise with the typical gastrointestinal symptoms, but 
also with extra-intestinal signs and/or symptoms such as those 
of the oral cavity. therefore, it is often detected lately or not 
diagnosed at all: approximately 70-80% of cases still escape 
diagnosis. the aim of this study is to observe the presence 
of alterations in the oral cavity of the celiac children and, in 
particular, the enamel hypoplasia, at variable degree (see aine 
classification), and recurrent aphthous Stomatitis (raS) in 
order to assess whether these have statistical significance such 
as to consider the dental visit useful to intercept the atypical 
forms of cD.
MetHoDS: We performed an accurate objective examina-
tion of the oral cavity in 38 celiac patients from 4 to 16 years 
(27 F - 71%, 11 M - 29%; average age 9.7, range 4-16), diag-
nosed according to the eSPgHaN criteria by a team of den-
tists at the dental clinic of the University of Foggia. the team 
searched changes in the enamel and the raS. the parents 
were asked to complete a survey in order to bring out data con-
cerning the manifestations of raS and to evaluate some other 
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